Related Experiment Video

Updated: Jul 2, 2026

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
09:54

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on: May 22, 2020

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

Dennis Bourdette, Vijayshree Yadav

    Current Neurology and Neuroscience Reports
    |August 21, 2008
    PubMed
    Summary

    No abstract available in PubMed .

    Related Concept Videos